adamantane has been researched along with Ache in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korchagina, D; Morozova, E; Nefedov, A; Pavlova, A; Ponomarev, K; Salakhutdinov, N; Suslov, E; Tolstikova, T; Volcho, K | 1 |
Fang, Q; Li, N; Pan, JX; Tang, HH; Wang, P; Wang, R; Wang, ZL; Yu, HP; Zhang, N; Zhang, R; Zhang, T; Zheng, T | 1 |
Botta, L; Corelli, F; Di Marzo, V; Ligresti, A; Maione, S; Mugnaini, C; Palazzo, E; Pasquini, S; Semeraro, T | 1 |
Bradshaw, E; Broom, DC; Buck, ME; Coombs, S; Cortright, DN; Ford, KK; Krause, JE; Matchett, M; Matson, DJ; Meade, R; Ochoa, R; Sun, SH; Wustrow, DJ; Yu, W; Yuan, J | 1 |
Kawahara, H; Mitchell, VA; Vaughan, CW | 1 |
Hammock, BD; Inceoglu, B; Jones, PD; Liu, JY; Morisseau, C; Rose, TE; Sanborn, JR | 1 |
Fitzpatrick, LR; Green, C; Maines, LW; Smith, CD | 1 |
Bihel, F; Bockel, F; Bourguignon, JJ; Elhabazi, K; Maldonado, R; Meziane, H; Mollereau, C; Moulédous, L; Petit-demoulière, B; Schmitt, M; Simonin, F; Trigo, JM; Zajac, JM | 1 |
Eiserich, JP; Hammock, BD; Inceoglu, B; Jinks, SL; Kim, IH; Kubala, L; Schmelzer, KR | 1 |
9 other study(ies) available for adamantane and Ache
Article | Year |
---|---|
Synthesis and Analgesic Activity of Amines Combining Diazaadamantane and Monoterpene Fragments.
Topics: Acetic Acid; Adamantane; Administration, Oral; Amines; Analgesics; Animals; Dose-Response Relationship, Drug; Mice; Molecular Structure; Monoterpenes; Pain; Pain Measurement; Structure-Activity Relationship | 2017 |
Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Topics: Adamantane; Analgesics; Animals; Dipeptides; Dose-Response Relationship, Drug; Drug Tolerance; Infusions, Intraventricular; Male; Mice; Neuropeptides; Oligopeptides; Pain; Pain Measurement; Receptors, Neuropeptide | 2015 |
Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo.
Topics: Adamantane; Analgesics; Animals; Carboxylic Acids; Humans; Mice; Pain; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2008 |
Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation.
Topics: Adamantane; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzamides; Benzoxazoles; Calcium; Disease Models, Animal; Humans; Inflammation; Inhibitory Concentration 50; Pain; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2X7 | 2008 |
Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
Topics: Adamantane; Animals; Cannabinoid Receptor Modulators; Endocannabinoids; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Imidazoles; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Miniature Postsynaptic Potentials; Neural Inhibition; Neurons; Neurotensin; Pain; Periaqueductal Gray; Piperidines; Presynaptic Terminals; Pyrazoles; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Neurotensin; Synaptic Transmission; Tetrodotoxin; Time Factors | 2009 |
1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.
Topics: Adamantane; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Epoxide Hydrolases; Humans; Male; Mice; Morphine; Pain; Piperidines; Rats; Rats, Sprague-Dawley; Solubility; Structure-Activity Relationship; Urea | 2010 |
Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2.
Topics: Adamantane; Animals; Apoptosis; Chondrocytes; Disease Models, Animal; Iodoacetates; Male; Osteoarthritis; Pain; Pain Measurement; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Rats; Rats, Wistar | 2011 |
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
Topics: Adamantane; Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Classical; Dipeptides; Drug Tolerance; Fentanyl; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pain; Receptors, Neuropeptide; Substance Withdrawal Syndrome | 2012 |
Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors.
Topics: Adamantane; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Drug Therapy, Combination; Enzyme Inhibitors; Epoxide Hydrolases; Lipopolysaccharides; Mice; Pain; Urea | 2006 |